Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilan Athauda

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2022
The Impact of Type 2 Diabetes in Parkinson's DiseaseDilan Athauda, James Evans, Anna Wernick, et al.
Nature Machine Intelligence|August 24, 2023
Prediction of mechanistic subtypes of Parkinson's using patient-derived stem cell modelsKarishma D'Sa, James R Evans, Gurvir S Virdi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2022
Diabetes and Neuroaxonal Damage in Parkinson's DiseaseNirosen Vijiaratnam, Michael Lawton, Raquel Real, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.
Brain Communications|March 5, 2026
Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assayNirosen Vijiaratnam, Christine Girges, Arthur Mitchell, et al.
Lancet (London, England)|August 8, 2017
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialDilan Athauda, Kate Maclagan, Simon S Skene, et al.
Chembiochem : a European Journal of Chemical Biology|July 28, 2018
Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal CellsDaniel R Whiten, Yukun Zuo, Laura Calo, et al.
Brain Communications|September 11, 2025
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's diseaseWeihua Li, Nicholas P Lao-Kaim, Runtian Li, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Combining biomarkers for prognostic modelling of Parkinson's diseaseNirosen Vijiaratnam, Michael Lawton, Amanda J Heslegrave, et al.
Journal of Neurochemistry|February 9, 2022
Amyloid processing in COVID-19-associated neurological syndromesOliver J Ziff, Nicholas J Ashton, Puja R Mehta, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2022
The Impact of Type 2 Diabetes in Parkinson's DiseaseDilan Athauda, James Evans, Anna Wernick, et al.
Nature Machine Intelligence|August 24, 2023
Prediction of mechanistic subtypes of Parkinson's using patient-derived stem cell modelsKarishma D'Sa, James R Evans, Gurvir S Virdi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2022
Diabetes and Neuroaxonal Damage in Parkinson's DiseaseNirosen Vijiaratnam, Michael Lawton, Raquel Real, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 15, 2019
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesEdwin Jabbari, John Woodside, Tong Guo, et al.
Brain Communications|March 5, 2026
Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assayNirosen Vijiaratnam, Christine Girges, Arthur Mitchell, et al.
Lancet (London, England)|August 8, 2017
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialDilan Athauda, Kate Maclagan, Simon S Skene, et al.
Chembiochem : a European Journal of Chemical Biology|July 28, 2018
Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal CellsDaniel R Whiten, Yukun Zuo, Laura Calo, et al.
Brain Communications|September 11, 2025
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's diseaseWeihua Li, Nicholas P Lao-Kaim, Runtian Li, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Combining biomarkers for prognostic modelling of Parkinson's diseaseNirosen Vijiaratnam, Michael Lawton, Amanda J Heslegrave, et al.
Journal of Neurochemistry|February 9, 2022
Amyloid processing in COVID-19-associated neurological syndromesOliver J Ziff, Nicholas J Ashton, Puja R Mehta, et al.
Pageof 6